ASH Research Collaborative
Accelerating Progress in Hematology
Scientific Review Subcommittee
Chair
- Punam Malik, MD
Appointed Members
- Kenneth I. Ataga, MD
- Daniel E. Bauer, MD, PhD
- Marina Cavazzana, MD, PhD
- Alice J. Cohen, MD
- Carlton Dampier, MD
- Payal C. Desai, MD
- Clinton H. Joiner, MD, PhD
- Abdullah Kutlar, MD
- Janet Kwiatkowski, MD
- Deepa Manwani, MD
- Patrick T. McGann, MD, PhD
- Morgan L. McLemore, MD
- Robin E. Miller, MD
- Caterina Patrizia Minniti, MD
- Jeffrey D. Lebensburger, DO
- Jennifer Rothman, MD
- Shalini Shenoy, MD
- Patricia A. Shi, MD
- John J Strouse, MD
- John F. Tisdale, MD
- Mark C. Walters, MD
- Russell E. Ware
Staff Liaison
- Nicole Mortier, MHS, PA-C – SCD CTN
Committee Mandate
The ASH Research Collaborative® Sickle Cell Disease (SCD) Clinical Trials Network (CTN) is a mission driven research effort using a collaborative network of clinical trial research sites, a comprehensive patient engagement approach, and optimized clinical trial operations to focused on advancing development of new and more effective therapeutics for individuals with sickle cell disease.
The Scientific Review Subcommittee, a subcommittee of the SCD CTN Oversight Committee, is tasked with:
- establishing criteria to review and select research projects,
- conducting review of proposed projects, and
- reviewing the growing scientific body of evidence in SCD research.
The membership of the Scientific Review Subcommittee includes a minimum of 12 members representing expertise in bioethics, biostatistics, bone marrow transplant, gene editing/therapy, SCD clinical trial, and SCD general medicine. This membership structure ensures that every scientific review has at least three to five conflict-free reviewers. In some instances, an ad hoc group may need to be established for protocol review based on sponsor request. Members participate in regular conference calls and email discussions as necessary.
The Chair of the Scientific Review Subcommittee serves as a liaison member of the SCD CTN Oversight Committee which convenes as necessary via conference call and up to three meetings per year.
ASH RESEARCH COLLABORATIVE
The ASH Research Collaborative (ASH RC) is a non-profit organization established by the American Society of Hematology (ASH) in 2017 to improve the lives of people affected by blood diseases by fostering collaborative partnerships to accelerate progress in hematology. Learn more about ASH RC